Skip to main content
Clinical Trials/NCT00962403
NCT00962403
Completed
Not Applicable

Evaluation of a Yoga Intervention for Post-Traumatic Stress Disorder

Brigham and Women's Hospital1 site in 1 country108 target enrollmentAugust 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-Traumatic Stress Disorder
Sponsor
Brigham and Women's Hospital
Enrollment
108
Locations
1
Primary Endpoint
Clinician Administered PTSD Scale (CAPS)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The main objective of this preliminary randomized controlled clinical trial is to establish efficacy and feasibility of a yoga-based treatment for PTSD in military veterans as compared to a delayed yoga treatment (waitlist control) group. Secondary objectives are to evaluate PTSD characteristics that may also be improved with the treatment and acceptability and compliance with the treatment.

Detailed Description

Specific Aims: 1. To evaluate the hypothesis that a 10-week yoga-based intervention will reduce PTSD severity to a statistically and clinically significant degree relative to a pretreatment baseline evaluation and to a waitlist control group. 2. To evaluate the hypothesis that PTSD patients will show improvement in regulation of physiological arousal in the autonomic nervous system relative to pretreatment. 3. To evaluate that hypothesis that symptoms associated with PTSD such as depression, anxiety, insomnia and quality of life will also be improved. 4. To evaluate the hypothesis that military veterans with PTSD can be successfully recruited into a yoga intervention study and will find the intervention acceptable and tolerable and will exhibit high compliance.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
May 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sat Bir Khalsa, PhD

Study Principal Investigator

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Male and female military veterans and active duty military personnel aged 18 and older
  • A DSM IV diagnosis of post-traumatic stress disorder
  • Potential subjects on medications are eligible to participate in the study
  • Potential subjects who receive ongoing medical or psychological treatment are eligible to participate in this study as long as these treatments do not include more than one hour weekly of relaxation and mind-body based stress reduction strategies (strategies directly related to meditation and yoga)
  • Potential subjects are eligible to participate in this study if they have sufficient mental and physical ability to fully participate in the parameters of the study. Subjects must be able to understand and comply with instructions in the group yoga sessions and home practice, complete questionnaires, participate in clinical interviews, and take part in all data collection activities. Subjects with severe mental or physical concerns that may prevent them from understanding and/or complying with the treatment will be excluded. For example, potential subjects confined to wheelchairs will not be eligible, although subjects with artificial limbs who are able to reasonably participate in the intervention may be deemed eligible. These determinations will be made during discussions with potential subjects on a case by case basis during the screening process

Exclusion Criteria

  • Potential subjects are ineligible if pregnant and in their third trimester.
  • Potential subjects are ineligible if they are confined to a wheel chair.

Outcomes

Primary Outcomes

Clinician Administered PTSD Scale (CAPS)

Time Frame: pre-intervention and 10 weeks

Secondary Outcomes

  • PTSD Checklist Military Version (PCL-M)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Impact of Events Scale - Revised (IES-R)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • 25-item Resilience Scale (RS)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Twenty-four-hour urinary samples(pre-intervention and 3 months post intervention)
  • 10-minute segment of a seated 30-minute electrocardiogram recording session(pre-intervention and 3 months post intervention)
  • Beck Depression Inventory (BDI)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Spielberger State Trait Anxiety Inventory (STAI)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Daily Sleep Wake Diaries(during intervention (weeks 1-10) and 3 months post intervention)
  • Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Credibility Expectancy Questionnaire (CEQ)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Body-Oriented State Questionnaire (BOSC)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • 5-Facet Mindfulness Questionnaire (FFMQ)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Perceived Stress Scale (PSS)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)
  • Yoga Follow-up Questionnaire(3 months post intervention)
  • PTSD Checklist Civilian Version (PCL-C)(pre-intervention, 5 weeks, 10 weeks and 3 months post intervention)

Study Sites (1)

Loading locations...

Similar Trials